CORC

在结果中检索

CORC

浏览/检索结果: 共18条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial 期刊论文
2019, 卷号: 24, 期号: 8, 页码: E702-E708
作者:  Zhou, Ai-Ping;  Bai, Yuxian;  Song, Yan;  Luo, Hong;  Ren, Xiu-Bao
收藏  |  浏览/下载：18/0  |  提交时间：2020/01/03
Irinotecan plus S-1 versus S-1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open-labeled phase 3 trial 期刊论文
2019, 卷号: 39, 期号: 1, 页码: 16
作者:  Huang, Jing;  Xu, Binghe;  Liu, Ying;  Huang, Junxing;  Lu, Ping
收藏  |  浏览/下载：31/0  |  提交时间：2020/01/03
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer: The FRESCO Randomized Clinical Trial 期刊论文
2018, 卷号: 319, 期号: 24, 页码: 2486-2496
作者:  Li Jin;  Qin Shukui;  Xu Rui-Hua;  Shen Lin;  Xu Jianming
收藏  |  浏览/下载：14/0  |  提交时间：2020/01/03
A randomized, double-blind, placebo-controlled, multi-centered phase 3 trial comparing fruquintinib versus placebo plus best supportive care in Chinese patients with metastatic colorectal cancer (FRESCO). 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:  Li, Jin;  Qin, Shukui;  Bai, Yuxian;  Deng, Yanhong;  Yang, Lei
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/04
A randomized, double-blind, placebo-controlled, multi-centered phase 3 trial comparing fruquintinib versus placebo plus best supportive care in Chinese patients with metastatic colorectal cancer (FRESCO). 期刊论文
2017, 卷号: 35
作者:  Li, Jin;  Qin, Shukui;  Bai, Yuxian;  Deng, Yanhong;  Yang, Lei
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04
An effective conjugation strategy for designing short peptide-based HIV-1 fusion inhibitors 期刊论文
2016, 卷号: 14, 期号: 33, 页码: 7875-7882
作者:  Liang, Guodong;  Wang, Huixin;  Chong, Huihui;  Cheng, Siqi;  Jiang, Xifeng
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04
Optimal regimen of trastuzumab in combination with oxaliplatin/capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial 期刊论文
2016, 卷号: 16, 页码: 68
作者:  Gong, Jifang;  Liu, Tianshu;  Fan, Qingxia;  Bai, Li;  Bi, Feng
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction 期刊论文
2016, 卷号: 34, 期号: 13, 页码: 1448-+
作者:  Li, Jin;  Qin, Shukui;  Xu, Jianming;  Xiong, Jianping;  Wu, Changping
收藏  |  浏览/下载：14/0  |  提交时间：2020/01/04
Anlotinib in metastatic renal cell carcinoma (mRCC) with a previous anti-VEGFR TKI: Preliminary results from a multicenter, phase II trial. 期刊论文
2016, 卷号: 34, 期号: 15
作者:  Zhou, Ai-Ping;  Bai, Yuxian;  Song, Van;  Li, Hangzhong;  Xie, Xiaodong
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04
Anlotinib versus sunitinib as first line treatment for metastatic renal cell carcinoma (mRCC): Preliminary results from a randomized phase II clinical trial 期刊论文
2016, 卷号: 34, 期号: 15
作者:  Zhou, Ai-Ping;  Ma, Jianhui;  Bai, Yuxian;  Song, Yan;  Li, Hangzhong
收藏  |  浏览/下载：12/0  |  提交时间：2020/01/04

©版权所有 ©2017 CSpace - Powered by CSpace